Vertex Pharmaceuticals Incorporated (VRTX)
VRTX Ben Graham Fair Value
Best stock ideas on the market right now
With Value Sense, you can find undervalued stocks list with intrinsic value. Discover more stock market investment ideas.
VRTX EPS growth & Dividend Yield
VRTX vs Peer Set: Ben Graham Fair Value Comparison
Explore more intrinsic value tools hub for VRTX
investors
worldwide
FAQ
What is Vertex Pharmaceuticals Incorporated's fair value according to the Ben Graham formula?
As of Sep 30, 2024, Vertex Pharmaceuticals Incorporated's fair value using the Ben Graham formula is $292.7 per share. This is calculated using Ben Graham formula, where EPS is ($1.9) and BVPS (Book Value Per Share) is $60.5. The current price of $409.9 suggests Vertex Pharmaceuticals Incorporated may be overvalued by this conservative metric.
What is Vertex Pharmaceuticals Incorporated earnings per share (EPS)?
Vertex Pharmaceuticals Incorporated earnings per share (EPS) for the twelve months ending Sep 30, 2024, was ($1.9), a (96.5%) growth year-over-year.
What is Vertex Pharmaceuticals Incorporated's margin of safety based on the Ben Graham analysis?
Vertex Pharmaceuticals Incorporated's margin of safety is negative 28.6%, calculated as (Graham Number - Current Price) / Current Price. A negative margin of safety suggests the stock doesn't provide the level of safety Graham typically sought in his investments.